
World-wide trends in patterns of care and survival from cancer: VENUSCANCER and CONCORD-4
Register
CONCORD is an ambitious global public health programme for the long-term surveillance of population-based cancer survival. In 2018, the third cycle of CONCORD (CONCORD-3) documented wide global differences in survival trends over the period 2000-2014, for most cancers in adults, and for brain tumours and haematological malignancies in children.
The VENUSCANCER project, embedded in the CONCORD programme, aims to examine whether global differences in survival for three of the most common cancers in women are attributable to differences in disease biology between populations, or patterns of care, or socio-economic status. Cancer registries were invited to submit data for a single year of complete incidence during 2015-2018, for which availability and completeness of high-resolution variables (e.g., stage, staging procedures, biomarkers, treatment) were highest. VENUSCANCER offered financial support to 11 registries in LMIC to enable collection of these data. We will present indicators of consistency with clinical treatment guidelines, derived from over 250,000 anonymised individual records of women diagnosed with breast, cervical or ovarian cancer between 2015 and 2018 in 39 countries, including 15 LMICs.
We will also present preliminary trends in age-standardised 5-year net survival from CONCORD-4, which has received anonymised individual records for over 95 million adults diagnosed with one of 22 cancers, and more than 600,000 children diagnosed with any cancer during the 30 years 1990-2019. Data were submitted by 381 population-based cancer registries in 75 countries world-wide.
